Literature DB >> 726520

The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.

G M Holder, J L Plummer, A J Ryan.   

Abstract

Curcumin labelled with deuterium and tritium was prepared. Oral and intraperitoneal doses of [3H]curcumin led to the faecal excretion of most of the radioactivity. 2. Intravenous and intraperitoneal doses of [3H]curcumin were well excreted in the bile of cannulated rats. 3. The major biliary metabolites were glucuronides of tetrahydrocurcumin and hexahydrocurcumin. A minor biliary metabolite was dihydroferulic acid together with traces of ferulic acid. Metabolites were identified using chemical ionization mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 726520     DOI: 10.3109/00498257809069589

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  77 in total

1.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 3.  Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases.

Authors:  Yang Sun; Tuo Yang; Rehana K Leak; Jun Chen; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2017       Impact factor: 4.388

Review 4.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

5.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

6.  The Chemistry of Gut Microbial Metabolism of Polyphenols.

Authors:  Jan F Stevens; Claudia S Maier
Journal:  Phytochem Rev       Date:  2016-03-11       Impact factor: 5.374

7.  Curcumin implants for continuous systemic delivery: safety and biocompatibility.

Authors:  Shyam S Bansal; Hina Kausar; Farrukh Aqil; Jeyaprakash Jeyabalan; Manicka V Vadhanam; Ramesh C Gupta; Srivani Ravoori
Journal:  Drug Deliv Transl Res       Date:  2011-08       Impact factor: 4.617

8.  Evaluation of mutagenic activity of turmeric extract containing curcumin, before and after activation with mammalian cecal microbial extract of liver microsomal fraction, in the Ames Salmonella test.

Authors:  R G Shah; M S Netrawali
Journal:  Bull Environ Contam Toxicol       Date:  1988-03       Impact factor: 2.151

9.  Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model.

Authors:  Vivek R Yadav; Sarasija Suresh; Kshama Devi; Seema Yadav
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246

10.  A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin.

Authors:  B Antony; B Merina; V S Iyer; N Judy; K Lennertz; S Joyal
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.